|Articles|March 1, 2011
- BioPharm International-03-02-2011
- Volume 2011 Supplement
- Issue 2
BioPharm International, March 2011 Supplement (PDF)
Global Outsourcing
Advertisement
Articles in this issue
almost 15 years ago
Supply-Chain Transformation: Strategic Necessity for the Life Sciencesalmost 15 years ago
Key Considerations When Outsourcing Cell-Culture Medium Developmentalmost 15 years ago
Sponsor-CMO Conflict Management for Clinical-Phase BiologicsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Fast Tracks Innovent’s Trispecific Antibody for Multiple Myeloma
2
FDA Priority Review of Subcutaneous Lecanemab Signals Shift in Alzheimer’s Treatment Delivery
3
Industrial-Scale Cell Therapy Automation Gains Traction with New Cellares Funding
4
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
5
